Literature DB >> 19575359

Comparison of several activity indices for the evaluation of endoscopic activity in UC: inter- and intraobserver consistency.

Taro Osada1, Toshifumi Ohkusa, Tetsuji Yokoyama, Tomoyoshi Shibuya, Naoto Sakamoto, Kazuko Beppu, Akihito Nagahara, Michiro Otaka, Tatsuo Ogihara, Sumio Watanabe.   

Abstract

BACKGROUND: This study evaluated inter- and intraobserver agreement in the assessment of ulcerative colitis (UC) activity using 4 established indices and a newly designed Modified 6-point Activity Index.
METHOD: In all, 279 endoscopic pictures of inflammatory lesions from 93 UC patients were displayed twice to 4 expert and 4 trainee endoscopists, at an interval of 1 month. Each picture was assessed for inflammatory changes using established indices (Matts, Schroeder [a.k.a. Mayo Score], Baron, and Blackstone) and our new Modified 6-point Activity Index. Weighted kappa statistics were used to estimate intra- and interobserver variation.
RESULTS: The Matts and Schroeder indices gave a "good" degree of concordance for expert endoscopists in terms of inter- and intraobserver agreements (0.74-0.78); this was not so evident with the Baron and Blackstone indices (0.61-0.73). For trainee endoscopists, all scores for inter- and intraobserver weighted kappa values using established indices (0.41-0.51) were lower than for the experts. The degree of concordance using the Modified 6-point Activity Index was rated as "good" for inter- and intraobserver agreements for expert endoscopists (0.65 and 0.79), and as "moderate" for trainee endoscopists (0.54 and 0.64).
CONCLUSIONS: Accurate assessment of UC disease activity from endoscopic findings benefited from experience. For expert endoscopists, the Matts and Schroeder indices proved the most reliable of the 4 established indices. Current endoscopic technologies may be adequate for assessing UC activity, particularly if modified to permit a finer classification of disease severity based on 6 grades, as with our newly developed Modified 6-point Activity Index.

Entities:  

Mesh:

Year:  2010        PMID: 19575359     DOI: 10.1002/ibd.21000

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  13 in total

Review 1.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Quantification of autofluorescence imaging can accurately and objectively assess the severity of ulcerative colitis.

Authors:  Kentaro Moriichi; Mikihiro Fujiya; Masami Ijiri; Kazuyuki Tanaka; Aki Sakatani; Tatsuya Dokoshi; Shugo Fujibayashi; Katsuyoshi Ando; Yoshiki Nomura; Nobuhiro Ueno; Shin Kashima; Takuma Gotoh; Junpei Sasajima; Yuhei Inaba; Takahiro Ito; Hiroki Tanabe; Yusuke Saitoh; Yutaka Kohgo
Journal:  Int J Colorectal Dis       Date:  2015-08-13       Impact factor: 2.571

3.  Evaluation of enterochromaffin cells and melatonin secretion exponents in ulcerative colitis.

Authors:  Cezary Chojnacki; Maria Wiśniewska-Jarosińska; Grażyna Kulig; Ireneusz Majsterek; Russel J Reiter; Jan Chojnacki
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

Review 4.  Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid?

Authors:  Robert Battat; Parambir S Dulai; Christopher Ma; Vipul Jairath; Brian G Feagan; William J Sandborn; Reena Khanna
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-04

5.  Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease.

Authors:  Tomoki Aomatsu; Atsushi Yoden; Kyoichi Matsumoto; Emi Kimura; Keisuke Inoue; Akira Andoh; Hiroshi Tamai
Journal:  Dig Dis Sci       Date:  2011-03-11       Impact factor: 3.199

6.  Autofluorescence imaging endoscopy for identification and assessment of inflammatory ulcerative colitis.

Authors:  Taro Osada; Atsushi Arakawa; Naoto Sakamoto; Hiroya Ueyama; Tomoyoshi Shibuya; Tatsuo Ogihara; Takashi Yao; Sumio Watanabe
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

Review 7.  Artificial Intelligence for Disease Assessment in Inflammatory Bowel Disease: How Will it Change Our Practice?

Authors:  Ryan W Stidham; Kento Takenaka
Journal:  Gastroenterology       Date:  2022-01-04       Impact factor: 22.682

8.  Application of Artificial Intelligence to Clinical Practice in Inflammatory Bowel Disease - What the Clinician Needs to Know.

Authors:  David Chen; Clifton Fulmer; Ilyssa O Gordon; Sana Syed; Ryan W Stidham; Niels Vande Casteele; Yi Qin; Katherine Falloon; Benjamin L Cohen; Robert Wyllie; Florian Rieder
Journal:  J Crohns Colitis       Date:  2022-03-14       Impact factor: 10.020

9.  MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis.

Authors:  Surajit Pathak; Alessia Rosaria Grillo; Melania Scarpa; Paola Brun; Renata D'Incà; Laura Nai; Antara Banerjee; Donatella Cavallo; Luisa Barzon; Giorgio Palù; Giacomo Carlo Sturniolo; Andrea Buda; Ignazio Castagliuolo
Journal:  Exp Mol Med       Date:  2015-05-22       Impact factor: 8.718

10.  Endoscopic assessment of the duodenum in dogs with inflammatory bowel disease.

Authors:  J E Slovak; C Wang; J A Morrison; K L Deitz; D N LeVine; C Otoni; R R King; L E Gerber; K R Hanson; A P Lundberg; A E Jergens
Journal:  J Vet Intern Med       Date:  2014 Sep-Oct       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.